58.700
58.70 (0%)
As of Jan 22, 2024
Mirati Therapeutics, Inc. [MRTX]
Source:
Company Overview
Mirati Therapeutics, Inc. is a clinical-stage oncology company developing novel therapeutics to address the genetic and immunological promoters of cancer.
| Country | United States |
| Headquarters | san diego, california |
| Phone Number | 858-332-3410 |
| Industry | manufacturing |
| CEO | David D. Meek |
| Website | mirati.com |